Felten R, Gottenberg JE. Response to: 'Correspondence on 'Interleukin 6 receptor inhibition in primary Sjogren syndrome: a multicentre double-blind randomised placebo-controlled trial'' by de Wolff et al. Ann Rheum Dis 2023;82:e149.
PMID: 33811032